• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOPERVISION MANUFACTURING, LTD. BIOFINITY ENERGYS (COMFILCON A)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOPERVISION MANUFACTURING, LTD. BIOFINITY ENERGYS (COMFILCON A) Back to Search Results
Lot Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Inflammation (1932); Red Eye(s) (2038); Swelling/ Edema (4577)
Event Date 08/13/2021
Event Type  Injury  
Manufacturer Narrative
Based on manufacturers investigation no root cause could be established.The relationship between the coopervision device and the incident is unconfirmed.
 
Event Description
It is reported that the patient was seen with symptoms of redness and swelling.The patient presented with a central extensive inflammatory infiltrate.Around the infiltrate on the epithelium level, numerous cells with halo around with suggest the possible presence of acanthamoeba cysts.Corneal scrapings taken on 15 august for testing, returned positive for pseudomonas aeruginosa.Sample also being tested for acanthamoeba, however, at the time of medical report (dated 20 august) no results returned.Patient was treated with brolene, chlorhexidine, and gentamicin.At follow-up visits patients condition continue to improve.Date of last recorded visit (dated 20 august), patient has a smaller number of inflammatory cells, but numerous halo cells around the infiltrate on the epithelium level remain and continue to suggest the possible presence of acanthamoeba cysts.Outside of the infiltration area, epithelium and proper morphology were seen, no mycelial hyphae (fungus) seen.Patient to be seen in three days for follow-up or seek care if condition worsens.No further medical records provided, patient outcome unknown.Good faith efforts have been made to obtain further information without success.As of the date of report, additional information is unknown.This event is being reported in an abundance of caution due to the confirmation of pseudomonas aeruginosa and potential for acanthamoeba keratitis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOFINITY ENERGYS (COMFILCON A)
Type of Device
BIOFINITY ENERGYS (COMFILCON A)
Manufacturer (Section D)
COOPERVISION MANUFACTURING, LTD.
south point
hamble unit 2
southamptom, hampshire SO31 4RF
UK  SO31 4RF
Manufacturer (Section G)
COOPERVISION MANUFACTURING, LTD.
south point
hamble unit 2
southamptom, hampshire SO31 4RF
UK   SO31 4RF
Manufacturer Contact
melissa torpey
5870 stoneridge drive
suite 1
pleasanton, CA 94588
5857569874
MDR Report Key12779596
MDR Text Key282122190
Report Number9614392-2021-00027
Device Sequence Number1
Product Code LPM
Combination Product (y/n)N
Reporter Country CodePL
PMA/PMN Number
P080011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/09/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/09/2021
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/11/2021
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient Age16 YR
Patient SexFemale
-
-